GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Greenyn Biotechnology Co Ltd (ROCO:6846) » Definitions » Beginning Cash Position

Greenyn Biotechnology Co (ROCO:6846) Beginning Cash Position : NT$533.5 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Greenyn Biotechnology Co Beginning Cash Position?

Greenyn Biotechnology Co's Beginning Cash Position for the quarter that ended in Mar. 2024 was NT$533.5 Mil.

Greenyn Biotechnology Co's quarterly Beginning Cash Position increased from Sep. 2023 (NT$543.8 Mil) to Dec. 2023 (NT$554.7 Mil) but then declined from Dec. 2023 (NT$554.7 Mil) to Mar. 2024 (NT$533.5 Mil).

Greenyn Biotechnology Co's annual Beginning Cash Position declined from Dec. 2021 (NT$384.1 Mil) to Dec. 2022 (NT$356.1 Mil) but then increased from Dec. 2022 (NT$356.1 Mil) to Dec. 2023 (NT$370.3 Mil).


Greenyn Biotechnology Co Beginning Cash Position Historical Data

The historical data trend for Greenyn Biotechnology Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenyn Biotechnology Co Beginning Cash Position Chart

Greenyn Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
95.97 164.70 384.14 356.13 370.30

Greenyn Biotechnology Co Quarterly Data
Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 370.30 396.00 543.81 554.68 533.51

Greenyn Biotechnology Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Greenyn Biotechnology Co Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Greenyn Biotechnology Co's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenyn Biotechnology Co (ROCO:6846) Business Description

Traded in Other Exchanges
N/A
Address
5th Floor, No 43 Keya Road, Daya District, Taichung, TWN
Greenyn Biotechnology Co Ltd has developed Insumate patented sequenced peptide, Antromax Antrodia cinnamomea mycelia, and Zymologist fermented liquid.

Greenyn Biotechnology Co (ROCO:6846) Headlines

No Headlines